US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
RSS Feeds

Biotechnology market research reports and industry analysis

1  2    4    6  7  8  9  10  
Nektar Therapeutics Partnering 2009-2014
8/1/2014 | published by: Current Partnering
... the information you require to better understand Nektar Therapeutics and its partnering interests and activities over the past seven years. On demand company reports are prepared upon purchase to ensure inclusion of the most up ...  |  read more...
USD 995
Novartis Partnering 2009-2014
8/1/2014 | published by: Current Partnering
... require to better understand Novartis and its partnering interests and activities over the past five years. On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and ...  |  read more...
USD 995
Genetic Disorders Partnering Terms and Agreements
8/1/2014 | published by: Current Partnering
... are discovery, preclinical or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. ...  |  read more...
USD 1,995
Marketed Stage Deals and Alliances of 2013
8/1/2014 | published by: Current Partnering
... healthcare companies during 2013. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals ...  |  read more...
USD 1,495
Clinical Stage Deals and Alliances of 2013
8/1/2014 | published by: Current Partnering
... healthcare companies during 2013. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals ...  |  read more...
USD 1,495
Discovery Stage Deals and Alliances of 2013
8/1/2014 | published by: Current Partnering
... healthcare companies during 2013. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals ...  |  read more...
USD 1,495
Public Health Deals and Alliances of 2013
8/1/2014 | published by: Current Partnering
... healthcare companies during 2013. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals ...  |  read more...
USD 1,495
Cleveland Biolabs, Inc. : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Cleveland Biolabs, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
USD 350
Compugen, Ltd. : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Compugen, Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers ...  |  read more...
USD 350
Cesca Therapeutics Inc. (KOOL) - Financial and Strategic SWOT Analysis Review
7/15/2014 | published by: GlobalData
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ...  |  read more...
USD 125
Personalized Medicine in Oncology Partnering Terms and Agreements
8/1/2014 | published by: Current Partnering
... by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter personalized medicine in oncology partnering deals. The majority of deals are discovery stage whereby the ...  |  read more...
USD 2,995
Monoclonal Antibodies Partnering Terms and Agreements
8/1/2014 | published by: Current Partnering
... obtains a right or an option right to license the licensors monoclonal antibody technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. This report provides details of the latest ...  |  read more...
USD 2,995
Microbial Identification Market Products (Consumables, Instruments, Services), Methods (Phenotypic, Genotypic) Application (Pharmaceutical, Diagnostic, Environmental, Food & Beverages), End User (Detection, Characterization) - Global Forecasts to 2019
7/28/2014 | published by: MarketsandMarkets
... the basis of products, methods, applications, end users, and geographies. Genotypic technology is expected to register highest growth in the microbial identification market. This favorable growth is attributed to the decrease in consumable costs (per ...  |  read more...
USD 4,650
WaferGen Bio:systems, Inc : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' WaferGen Bio-systems, Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
USD 350
Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four-Factor PCCs and Recombinant Products to Drive Market
7/14/2014 | published by: GBI Research
... “Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four-Factor PCCs and Recombinant Products to Drive Market”, which provides in-depth analysis of the critical care market in the US, UK, France, ...  |  read more...
USD 4,995
Baxter International Inc.: Competitive Benchmarking Report
8/1/2014 | published by: The Business Analysts' Group
... comparative analysis on these metrics, this Competitive Benchmarking Report has two USPs, which distinguishes this report from any other available competitive benchmarking report on this company: 1. Industry Analysis Section: This section covers an analytical ...  |  read more...
USD 1,799
Charles River Laboratories International, Inc.: Competitive Benchmarking Report
8/1/2014 | published by: The Business Analysts' Group
... comparative analysis on these metrics, this Competitive Benchmarking Report has two USPs, which distinguishes this report from any other available competitive benchmarking report on this company: 1. Industry Analysis Section: This section covers an analytical ...  |  read more...
USD 1,799
Emergent Biosolutions, Inc.: Competitive Benchmarking Report
8/1/2014 | published by: The Business Analysts' Group
... comparative analysis on these metrics, this Competitive Benchmarking Report has two USPs, which distinguishes this report from any other available competitive benchmarking report on this company: 1. Industry Analysis Section: This section covers an analytical ...  |  read more...
USD 1,799
Taiyen Biotech Co., Ltd - Company Capsule
7/18/2014 | published by: Canadean Ltd
... key facts, major products and services, financial ratios, financial analysis, key employees, company locations and subsidiaries. Summary This report is a crucial resource for industry executives and anyone looking to access key information about Taiyen ...  |  read more...
USD 99
Global Genomics and Proteomics Analytical Instruments Market : 2014-2018
7/14/2014 | published by: TechNavio - Infiniti Research Ltd.
... Instruments Market: Agilent Technologies Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Illumina Inc. , PerkinElmer Inc., Thermo Fisher Scientific Inc. , Becton Dickinson and Co., Bruker Corp., GE Healthcare, Jasco Inc., Jeol Ltd., Luminex ...  |  read more...
USD 2,500
Global Synthetic Biology Market : 2014-2018
7/14/2014 | published by: TechNavio - Infiniti Research Ltd.
... E. I. du Pont de Nemours and Co., Thermo Fisher Scientific Inc., Synthetic Genomics Inc., Algenol Biofuels Inc., ATG:biosynthetics GmbH, Bayer AG, Bioneer Corp., Biosearch Technologies Inc., Bristol-Myers Squibb Co., CBC Comprehensive Biomarker Center GmbH, ...  |  read more...
USD 2,500
Antibodies in Oncology: Drug Pathway Analyzer 2014
7/15/2014 | published by: BioSeeker Group AB
... intracellular signaling pathways for the treatment of more than 107 different tumor types. The rational for this plethora of treatment strategies is based on our increasing understanding of the 264 drug targets that are included ...  |  read more...
USD 6,746
Biologicals in Oncology: Drug Pathway Analyzer 2014
7/15/2014 | published by: BioSeeker Group AB
... intracellular signaling pathways for the treatment of more than 137 different tumor types. The rational for this plethora of treatment strategies is based on our increasing understanding of the 547 drug targets that are included ...  |  read more...
USD 11,025
RNAs (miRNA, RNAi & siRNA) in Oncology: Drug Pathway Analyzer 2014
7/15/2014 | published by: BioSeeker Group AB
... drugs known to affect more than 157 specific intracellular signaling pathways for the treatment of more than 25 different tumor types. The rational for this plethora of treatment strategies is based on our increasing understanding ...  |  read more...
USD 2,246
Biologicals in Oncology Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
... developing 1686 biological drugs in 3815 developmental projects in cancer. In addition, there are 28 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 932 drugs. Biologicals In ...  |  read more...
USD 11,246
1  2    4    6  7  8  9  10